What We Do

Encapsulated Immune-Modulatory Biologics

At Therapyx we develop sustained-release microparticulate immune-modulatory biologics using a novel technology platform (EXStaM) for oral or mucosal delivery.  The products we develop are geared toward the prevention and treatment of infection, immune-mediated inflammatory diseases, and cancer.  We have a broad pipeline of products at discovery and preclinical stages.

Innovating Solutions for the Diseases of Today

Our most advanced products include PCX12™ for the treatment of Pancreatic Cancer and GneX12™ for the treatment/prevention of gonorrheae.